FILTER
LATEST INTERVIEWS
Tim Livesey
CEO, ORIOLE RESOURCES
Oriole Resources explains its ambitions exploring for gold in Cameroon and Senegal.
Chris McQuillan
DIRECTOR, PW NIGERIA MINING LIMITED (PWN MINING)
PW Nigeria Mining explains its move into Nigeria’s underdeveloped mining industry.
Stéphane Cervellera
WESTERN AFRICA MANAGER, TITANOBEL
Titanobel explains its plans to expand its explosive business around the world.
German Torres
CEO, BRENNTAG LATIN AMERICA
“The two challenges of digitalization are how to manage the substantial high number of transactions and how to manage the distribution channels. Having a nice website or platform is useless if you cannot deliver.”
Olivier Terra
MANAGING DIRECTOR, BOLLORÉ TRANSPORT & LOGISTICS ZAMBIA
Bolloré Zambia comment on the logistics issues that they deal with in landlocked Zambia.
Todd Burns
PRESIDENT, CYPHER ENVIRONMENTAL
Cypher Environmental provides solutions for stabilizing roads and suppressing dust in an environmentally friendly manner.
Juan Moncada
MANAGING DIRECTOR LATIN AMERICA, EASTMAN
Eastman Latin America has maintained profitability during H1 2020 and continues introducing new sustainable products.
Wilson Miranda
GENERAL MANAGER, CONFIPETROL ANDINA
Confipetrol is extending the services that it offers to mining clients in Peru to Chile and Ecuador.
Vincent Mascolo
CEO, IRON RIDGE RESOURCES
IronRidge’s focus on lithium and gold gives investors exposure to rapidly growing lithium technology markets while hedging prominent global economic uncertainty via a large gold exploration portfolio.
Paul Roberts
MANAGING DIRECTOR, PREDICTIVE DISCOVERY
Predictive Discovery explains progress at its Bankan discovery in Guinea, which holds a special place in the company’s West African portfolio.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
